DexCom to invest $75M in smart ring firm ŌURA
DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.
Oura valued at $5B following deal with medical device firm Dexcom
Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.
Fierce Healthcare17h
Smart ring maker Oura picks up $75M series D, inks strategic partnership with Dexcom
Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which ...
pharmaphorum23h
FDA clears first OTC glucose biosensor, from Dexcom
The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...